# Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility

> **NCT03852979** · PHASE2 · TERMINATED · sponsor: **The Netherlands Cancer Institute** · enrollment: 1 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin
- **PROCEDURE:** conisation

## Key facts

- **NCT ID:** NCT03852979
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** study is merged with CONTESSA study
- **Last updated:** 2020-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03852979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03852979, "Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03852979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*